Polaryx Therapeutics, Inc. — Financials

XNCM:PLYX · NASDAQ CAPITAL MARKET

Polaryx Therapeutics, Inc. (PLYX) Financials | Ticker

	FY25	Trend
Revenue
Expenses
Operating Expenses	$7.8M
Profit
Operating Profit	-$7.8M
Profit Before Tax	-$9.0M
Profit After Tax	-$9.0M
Attributable to Shareholders	-$9.0M
Basic EPS	-$0
Diluted EPS	-$0

Currency: USDPeriods: 1

Source: Annual Reports